CRP and metabolic dysfunction-associated steatotic liver disease: Patients in the non-obese NAFLD group had significantly higher levels of CRP (0.2 ± 0.3 ng/mL vs. 0.1 ± 0.2 ng/mL, p < 0.001) and ferritin (130.7 ± 129.4 ng/mL vs. 76.0 ± 57.6 ng/mL, p = 0.001).